Article info

PDF
Adherence and preference of intravenous zoledronic acid for osteoporosis versus other bisphosphonates

Authors

  1. Correspondence to Dr Susana Sánchez-Fidalgo, Department of Pharmacology, University Hospital Valme, Avenida de Bellavist, Seville 41012, Spain; fidalgo{at}us.es
View Full Text

Citation

Fobelo Lozano MJ, Sánchez-Fidalgo S
Adherence and preference of intravenous zoledronic acid for osteoporosis versus other bisphosphonates

Publication history

  • Received 7 March 2017
  • Revised 13 July 2017
  • Accepted 1 August 2017
  • Published online 20 September 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.